Cannabidiol selectively inhibits the contraction of rat small resistance arteries: Possible role for CGRP and voltage-gated calcium channels

This publication has 27 references indexed in Scilit:

• Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
  Journal Of Hypertension, 2020
• Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
  New England Journal of Medicine, 2018
• Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
  Neurology, 2018
• Distortion of K_Bestimates of endothelin‐1 ET_Aand ET_Breceptor antagonists in pulmonary arteries: Possible role of an endothelin‐1 clearance mechanism
  Pharmacology Research & Perspectives, 2017
• Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
  New England Journal of Medicine, 2017
• Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
  Epilepsia, 2015
• Endothelial atypical cannabinoid receptor: do we have enough evidence?
  British Journal of Pharmacology, 2014
• Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery
  British Journal of Pharmacology, 2003
• Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens
  British Journal of Pharmacology, 2001
• Techniques to study the pharmacodynamics of isolated large and small blood vessels
  Journal of Pharmacological and Toxicological Methods, 2000